PUBLISHER: The Business Research Company | PRODUCT CODE: 1947046
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947046
A real-time blood glucose continuous glucose monitoring (CGM) patch is a wearable device that continuously monitors glucose levels in the interstitial fluid beneath the skin. It transmits glucose readings in real time to a connected display or mobile device, enabling continuous tracking of glucose trends. The patch functions through a small sensor and transmitter that provide frequent data updates without requiring fingerstick measurements.
The primary product types of real-time blood glucose continuous glucose monitoring (CGM) patches are wearable CGM patches and implantable CGM patches. A wearable CGM patch is a discreet, skin-worn sensor that continuously tracks glucose levels and transmits real-time data to support management of diet, activity, and medication. These patches incorporate various technologies, including enzymatic and non-enzymatic systems, and are distributed through channels such as online pharmacies, retail pharmacies, hospital pharmacies, and other outlets. They are used for applications including type 1 diabetes, type 2 diabetes, gestational diabetes, and other conditions, and are utilized by hospitals, clinics, homecare settings, diagnostic centers, and other end-users.
Tariffs have introduced cost pressures and supply chain disruptions in the real-time blood glucose continuous glucose monitoring (CGM) patch market by increasing the prices of electronic components, biosensors, and wireless modules sourced from international suppliers. These cost increases have particularly affected wearable and implantable CGM patch manufacturers, with Asia-Pacific manufacturing hubs such as China and South Korea and high-consumption regions such as North America being most impacted. Distribution channels such as hospital pharmacies and online pharmacies have also faced pricing volatility due to higher import duties. However, tariffs have encouraged regional manufacturing, supplier diversification, and localized production, which is strengthening supply chain resilience and supporting long-term market stability.
The real-time blood glucose continuous glucose monitoring (cgm) patch market research report is one of a series of new reports from The Business Research Company that provides real-time blood glucose continuous glucose monitoring (cgm) patch market statistics, including real-time blood glucose continuous glucose monitoring (cgm) patch industry global market size, regional shares, competitors with a real-time blood glucose continuous glucose monitoring (cgm) patch market share, detailed real-time blood glucose continuous glucose monitoring (cgm) patch market segments, market trends and opportunities, and any further data you may need to thrive in the real-time blood glucose continuous glucose monitoring (cgm) patch industry. This real-time blood glucose continuous glucose monitoring (cgm) patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The real-time blood glucose continuous glucose monitoring (cgm) patch market size has grown rapidly in recent years. It will grow from $7.04 billion in 2025 to $8.08 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to increasing diabetes prevalence, rising awareness of glucose self-monitoring, growing adoption of wearable medical devices, expanding hospital-based diabetes management, improving sensor accuracy.
The real-time blood glucose continuous glucose monitoring (cgm) patch market size is expected to see rapid growth in the next few years. It will grow to $13.89 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to integration of real-time data analytics, increasing telehealth adoption, demand for personalized diabetes management, expansion of homecare diagnostics, rising investment in continuous monitoring technologies. Major trends in the forecast period include rising adoption of patch-based glucose monitoring, growing demand for real-time glucose visibility, shift toward non-invasive and minimally invasive monitoring, expansion of home-based diabetes management, increased use of continuous monitoring in early diagnosis.
The rising prevalence of diabetes is expected to drive the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient insulin production or insulin resistance. Its prevalence is increasing as rising obesity rates lead to higher insulin resistance, disrupting blood sugar regulation and significantly increasing the risk of developing type 2 diabetes. Real-time blood glucose CGM patches enable people with diabetes to continuously monitor glucose levels, providing timely alerts for hyperglycemia or hypoglycemia, supporting informed dietary, medication, and lifestyle decisions, and improving overall disease management while reducing complication risks. For example, in June 2024, the National Health Service in the UK reported that in 2023, over 549,000 additional individuals in England were identified at risk of type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia or prediabetes registered with a GP to 3,615,330, up nearly 20% from 3,065,825 in 2022. This demonstrates how the rising prevalence of diabetes is driving market growth.
Key companies in the real-time blood glucose CGM patch market are focusing on innovative products such as over-the-counter continuous glucose monitoring sensors to increase access and convenience. Over-the-counter CGM sensors are wearable devices that track glucose levels in real time without a prescription, enabling users to continuously monitor glucose, understand lifestyle impacts, and manage or prevent diabetes more easily. For instance, in September 2024, Dexcom Inc., a US-based diabetes technology company, launched Stelo, its first OTC CGM patch in the United States. The small, wearable sensor attaches to the back of the upper arm and provides real-time glucose readings directly to a smartphone app without fingersticks. Designed for people with type 2 diabetes not using insulin and those with prediabetes, Stelo delivers personalized insights on how diet, exercise, and sleep affect glucose levels. The device offers up to 15-day wear, waterproofing, spike and pattern detection, and integrates with Dexcom's glucose sensing technology, making continuous glucose monitoring more accessible and actionable for a wider population.
In January 2024, Trinity Biotech plc, an Ireland-based diagnostics company, acquired the biosensor and CGM assets of Waveform Technologies Inc. for $12.5 million in cash and 9 million ADSs. This acquisition enables Trinity Biotech to enter the growing biosensor and CGM market by leveraging Waveform's needle-free CGM technology to develop next-generation wearable biosensors, target additional biomarkers, and promote broader global adoption of affordable diabetes care tools. Waveform Technologies Inc. is a US-based company specializing in real-time blood glucose CGM patch technology.
Major companies operating in the real-time blood glucose continuous glucose monitoring (cgm) patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., MicroTech Medical Inc., Zhejiang POCTech Co. Ltd., SiBio Technology Co. Ltd., Metronom Health Inc., Nemaura Medical Inc., PKvitality SAS, Nutromics Ltd., EOFlow Co. Ltd., i-SENS Inc., Sinocare Inc., Afon Technology Ltd., LifePlus Inc., Ultrahuman Healthcare Pvt. Ltd., Roche Diabetes Care AG, Ascensia Diabetes Care Holdings AG
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as remote patient monitoring and telehealth support, subscription and replacement programs, distribution and logistics management, clinical and diagnostic glucose monitoring services, research and development for sensor innovation, customer training and technical support, and reimbursement or healthcare partnership services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of microneedles paper-type biodegradable sensor, disposable patch sensor, and adhesive-backed sensor. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses real-time blood glucose continuous glucose monitoring (cgm) patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for real-time blood glucose continuous glucose monitoring (cgm) patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real-time blood glucose continuous glucose monitoring (cgm) patch market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.